2019. The requirements for manufacturing highly active or sensitising drugs comparing Good Manufacturing Practices. Acta Biomedica Atenei Parmensis. 90, 2 (May 2019), 288–299. DOI:https://doi.org/10.23750/abm.v90i2.8340.